Epsilon M&A Deal Report - Yeni Ilaç ve Hammaddeleri San ve Tic
Transaction Multiples for the Valuation of Private Companies
Recordati / Yeni Ilaç ve Hammaddeleri San ve Tic
- Pharmaceuticals & Cosmetics R&W > Retail and Wholesale ('R&W') > Drugs Retailers
- Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Pharmaceuticals
EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
---|---|---|---|---|---|---|---|---|
Historic | ![]() |
![]() |
![]() |
|||||
Current |
![]() |
Multiple available |
n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Drugs Retailers » = 53
- Number of EMAT Reports / sub-sector « Pharmaceuticals » = 130
Date | Acquirer | Target | Country | Multiples | See details |
19/11/2008 | GlaxoSmithKline | AZ Tika | Sweden | * | 19597 |
17/12/2008 | Wyeth Pharmaceuticals | Thiakis | England | * | 19596 |
Source: Epsilon Research / EMAT